* Aveanna Healthcare Holdings Inc AVAH.OQ AVAH.O is
expected
to show a rise in quarterly revenue when it reports results on
May 9 for the period ending March 31 2024
* The Atlanta Georgia-based company is expected to report a
3.8% increase in revenue to $483.976 million from $466.41
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Aveanna Healthcare
Holdings
Inc is for a loss of 5 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aveanna
Healthcare Holdings Inc is $2.75, above its last closing price
of $2.37.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.02 -0.02 -0.02 Met 15.8
Sep. 30 2023 -0.03 -0.03 -0.03 Met -12.5
Jun. 30 2023 -0.04 -0.04 -0.02 Beat
Jan. 1 0001 -0.06 -0.05 18.6
Jan. -0.01 -0.03 -81
1 0001
Sep. 30 2022 0.03 0.04 -0.03 Missed -185.7
Jan. 1 0001 0.04 0.06 0.03 Missed -48.7
Mar. 31 2022 0.06 0.06 0.04 Missed -33.4
This summary was machine generated May 7 at 18:54 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)